Marks Gilbert Lynn 4
4 · AN2 Therapeutics, Inc. · Filed Dec 23, 2024
Insider Transaction Report
Form 4
Marks Gilbert Lynn
Director
Transactions
- Award
Common Stock
2024-12-19+8,972→ 31,802 total
Footnotes (1)
- [F1]Represents shares issued in lieu of cash compensation under the issuer's non-employee director compensation policy. All shares vest immediately.